SA
Log In
ABMD
OverviewIntelligenceChart
+0.00%(+0.00)
Open
380.78
Prev Close
381.02
Day High
381.28
Day Low
380.55
Volume
15.7M
Avg Volume
1.7M
52W High
381.99
52W Low
219.85
Signal
Leaning Bullish1↑1!
Price
1→
Move→+0.00%Quiet session
Volume
1↑
Volume↑9.2× avgSurge — unusual activity
Technical
1→
RSI↑RSI 76Overbought
PRICE
Prev Close
381.02
Open
380.78
Day Range380.55 – 381.28
380.55
381.28
52W Range219.85 – 381.99
219.85
381.99
99% of range
VOLUME & SIZE
Avg Volume
1.7M
FUNDAMENTALS
P/E Ratio
65.4x
Premium valuation
EPS (TTM)
—
Div Yield
No dividend
Beta
1.37
Market-like
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +10% YoY · 82% gross margin
Valuation
EXPENSIVE
P/E 65x vs ~20x sector
Health
STRONG
CR 7.1 · FCF $5.49/sh
Bullish
Key MetricsTTM
Market Cap$17.18B
Revenue TTM$1.07B
Net Income TTM$266.76M
Free Cash Flow$217.22M
Gross Margin81.8%
Net Margin13.2%
Operating Margin36.1%
Return on Equity9.6%
Return on Assets8.2%
Debt / Equity0.00
Current Ratio7.05
EPS TTM$3.00
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
4 strong1 watch1 concern
65/100
Liquidity
7.05Strong
Leverage
0.00Strong
Coverage
7.5xStrong
ROE
9.6%Watch
ROIC
17.4%Strong
Cash
$133MConcern
ANALYST COVERAGE18 analysts
HOLD
Buy
844%
Hold
1056%
8 Buy (44%)10 Hold (56%)0 Sell (0%)
Full report →
Stock Health
Composite Score
2 of 4 signals bullish
8/10
Technicals
●
RSI RangeRSI 76 — Overbought, caution
~
Fundamentals
●
Last EarningsBeat estimates
✓
●
Analyst ConsensusHold
~
●
LiquidityCurrent Ratio 7.05 — healthy liquidity
✓

1 signal unavailable — limited data for this stock

Upcoming Events
EEarnings ReportMay 6, 2026
Tomorrow
DEx-Dividend DateAug 3, 2026
In 90 days
PDividend PaymentAug 20, 2026
In 107 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Technical SetupBULLISH
Technicals →

Trend

▲ UptrendGolden Cross · 50D leads 200D by 20.5%

+8.4% vs SMA 50 · +30.6% vs SMA 200

Momentum

RSI76.2
Overbought — pullback risk
MACD+13.57
Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$382.0+0.3%
EMA 50
$381.0+0.0%
Current
$381.0
EMA 200
$354.3-7.0%
52W Low
$219.8-42.3%
52-Week RangeNear 52-week high
$219.899th %ile$382.0
Earnings & Analysts
🔥Beat 8 consecutive quarters
Earnings HistoryABMD
Last 8Q
+17.6%avg beat
Beat 8 of 8 quarters↓ Estimates falling
+19%
Q1'21
+13%
Q2'21
+34%
Q3'21
+6%
Q4'21
+19%
Q1'22
+6%
Q2'22
+18%
Q3'22
+25%
Q4'22
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
Sutter Martin PDir
$424K
Nov 15
SELL
Sutter Martin PDir
$325K
Nov 15
SELL
Sutter Martin PDir
$696K
Nov 16
SELL
Sutter Martin PDir
$53K
Nov 16
SELL
Began Marc ADir
$747K
Nov 4
SELL
Plano Matthew T.Dir
$368K
Nov 1
SELL
Financials

INSTITUTIONAL OWNERSHIP

13-F Filings →
1
Autus Asset Management, LLC
0▼
2
SEEYOND
0▼
3
EATON VANCE MANAGEMENT
127K▲
4
AlphaCrest Capital Management LLC
7K▼
5
Corient Capital Partners, LLC
5K▲
6
Redpoint Investment Management Pty Ltd
1K▼
7
BLUESTEIN R H & CO LLC
1K▼
8
American Portfolios Advisors
691▼
News & Activity

ABMD News

20 articles · 4h ago

About

Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.

Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
CEO
Michael Minogue
Website
www.abiomed.com ↗
Thorsten SiessExecutive Vice President & Chief Technology Officer
Andrew J. GreenfieldExecutive Vice President & Chief Commercial Officer
Marc A. BeganExecutive Vice President, Gen. Counsel & Sec.

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance